カテゴリー： 世界, 医療/バイオ, LP Information

世界の非オピオイド局所鎮痛剤市場予測 2023年-2029年

【英語タイトル】Global Non-opioid Topical Pain Relief Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC08034）・商品コード：LP23DC08034
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：119
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の非オピオイド局所鎮痛剤市場」は、過去の販売実績から2022年の世界の非オピオイド局所鎮痛剤の総販売量を検討し、2023年から2029年の予測される非オピオイド局所鎮痛剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の非オピオイド局所鎮痛剤の市場規模を掲載し、XXX百万米ドル規模の世界の非オピオイド局所鎮痛剤市場の詳細な分析を提供します。本インサイトレポートは、世界の非オピオイド局所鎮痛剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の非オピオイド局所鎮痛剤市場における各社の独自のポジションをより深く理解するために、非オピオイド局所鎮痛剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の非オピオイド局所鎮痛剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。非オピオイド局所鎮痛剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。非オピオイド局所鎮痛剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。非オピオイド局所鎮痛剤のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

非オピオイド局所鎮痛剤の世界主要メーカーとしては、Johnson and Johnson、 GlaxoSmithKline、 Pfizer、 Hisamitsu、 Mylan、 Reckitt Benckiser Group、 Sanofi、 Teva Pharmaceutical、 Sun Pharmaceutical Industries、 Lingrui Pharmaceutical、 Tibet Cheezheng Tibetan Medicine、 China Resources Sanjiu Medical & Pharmaceutical、 Topical BioMedics、 AdvaCare Pharma、 Abacus Health Productsなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の非オピオイド局所鎮痛剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では非オピオイド局所鎮痛剤市場をセグメンテーションし、種類別 (処方鎮痛剤、市販鎮痛剤)、用途別 (薬局、クリニック、病院、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：処方鎮痛剤、市販鎮痛剤

・用途別区分：薬局、クリニック、病院、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の非オピオイド局所鎮痛剤市場の10年間の市場状況・展望は？
・世界および地域別に見た非オピオイド局所鎮痛剤市場成長の要因は何か？
・非オピオイド局所鎮痛剤の市場機会はエンドマーケットの規模によってどのように変化するのか？
・非オピオイド局所鎮痛剤のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：非オピオイド局所鎮痛剤の年間販売量2018-2029、地域別現状・将来分析
・非オピオイド局所鎮痛剤の種類別セグメント：処方鎮痛剤、市販鎮痛剤
・非オピオイド局所鎮痛剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・非オピオイド局所鎮痛剤の用途別セグメント：薬局、クリニック、病院、その他
・非オピオイド局所鎮痛剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の非オピオイド局所鎮痛剤市場
・企業別のグローバル非オピオイド局所鎮痛剤市場データ：2018-2023年の年間販売量、市場シェア
・企業別の非オピオイド局所鎮痛剤の年間売上：2018-2023年の売上、市場シェア
・企業別の非オピオイド局所鎮痛剤販売価格
・主要企業の非オピオイド局所鎮痛剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

非オピオイド局所鎮痛剤の地域別レビュー
・地域別の非オピオイド局所鎮痛剤市場規模2018-2023：年間販売量、売上
・主要国別の非オピオイド局所鎮痛剤市場規模2018-2023：年間販売量、売上
・南北アメリカの非オピオイド局所鎮痛剤販売の成長
・アジア太平洋の非オピオイド局所鎮痛剤販売の成長
・ヨーロッパの非オピオイド局所鎮痛剤販売の成長
・中東・アフリカの非オピオイド局所鎮痛剤販売の成長

南北アメリカ市場
・南北アメリカの国別の非オピオイド局所鎮痛剤販売量、売上（2018-2023）
・南北アメリカの非オピオイド局所鎮痛剤の種類別販売量
・南北アメリカの非オピオイド局所鎮痛剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の非オピオイド局所鎮痛剤販売量、売上（2018-2023）
・アジア太平洋の非オピオイド局所鎮痛剤の種類別販売量
・アジア太平洋の非オピオイド局所鎮痛剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の非オピオイド局所鎮痛剤販売量、売上（2018-2023）
・ヨーロッパの非オピオイド局所鎮痛剤の種類別販売量
・ヨーロッパの非オピオイド局所鎮痛剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の非オピオイド局所鎮痛剤販売量、売上（2018-2023）
・中東・アフリカの非オピオイド局所鎮痛剤の種類別販売量
・中東・アフリカの非オピオイド局所鎮痛剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・非オピオイド局所鎮痛剤の製造コスト構造分析
・非オピオイド局所鎮痛剤の製造プロセス分析
・非オピオイド局所鎮痛剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・非オピオイド局所鎮痛剤の主要なグローバル販売業者
・非オピオイド局所鎮痛剤の主要なグローバル顧客

地域別の非オピオイド局所鎮痛剤市場予測レビュー
・地域別の非オピオイド局所鎮痛剤市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・非オピオイド局所鎮痛剤の種類別市場規模予測
・非オピオイド局所鎮痛剤の用途別市場規模予測

主要企業分析
Johnson and Johnson、 GlaxoSmithKline、 Pfizer、 Hisamitsu、 Mylan、 Reckitt Benckiser Group、 Sanofi、 Teva Pharmaceutical、 Sun Pharmaceutical Industries、 Lingrui Pharmaceutical、 Tibet Cheezheng Tibetan Medicine、 China Resources Sanjiu Medical & Pharmaceutical、 Topical BioMedics、 AdvaCare Pharma、 Abacus Health Products
・企業情報
・非オピオイド局所鎮痛剤製品
・非オピオイド局所鎮痛剤販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Non-opioid Topical Pain Relief market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Non-opioid Topical Pain Relief is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Non-opioid Topical Pain Relief is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Non-opioid Topical Pain Relief is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Non-opioid Topical Pain Relief players cover Johnson and Johnson, GlaxoSmithKline, Pfizer, Hisamitsu, Mylan, Reckitt Benckiser Group, Sanofi, Teva Pharmaceutical and Sun Pharmaceutical Industries, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Non-opioid Topical Pain Relief Industry Forecast” looks at past sales and reviews total world Non-opioid Topical Pain Relief sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-opioid Topical Pain Relief sales for 2023 through 2029. With Non-opioid Topical Pain Relief sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-opioid Topical Pain Relief industry.
This Insight Report provides a comprehensive analysis of the global Non-opioid Topical Pain Relief landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-opioid Topical Pain Relief portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-opioid Topical Pain Relief market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-opioid Topical Pain Relief and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-opioid Topical Pain Relief.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-opioid Topical Pain Relief market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Prescription Pain Relief
Over-The-Counter Pain Relief
Segmentation by application
Pharmacy
Clinic
Hospital
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Johnson and Johnson
GlaxoSmithKline
Pfizer
Hisamitsu
Mylan
Reckitt Benckiser Group
Sanofi
Teva Pharmaceutical
Sun Pharmaceutical Industries
Lingrui Pharmaceutical
Tibet Cheezheng Tibetan Medicine
China Resources Sanjiu Medical & Pharmaceutical
Topical BioMedics
AdvaCare Pharma
Abacus Health Products
Key Questions Addressed in this Report
What is the 10-year outlook for the global Non-opioid Topical Pain Relief market?
What factors are driving Non-opioid Topical Pain Relief market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-opioid Topical Pain Relief market opportunities vary by end market size?
How does Non-opioid Topical Pain Relief break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-opioid Topical Pain Relief Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Non-opioid Topical Pain Relief by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Non-opioid Topical Pain Relief by Country/Region, 2018, 2022 & 2029
2.2 Non-opioid Topical Pain Relief Segment by Type
2.2.1 Prescription Pain Relief
2.2.2 Over-The-Counter Pain Relief
2.3 Non-opioid Topical Pain Relief Sales by Type
2.3.1 Global Non-opioid Topical Pain Relief Sales Market Share by Type (2018-2023)
2.3.2 Global Non-opioid Topical Pain Relief Revenue and Market Share by Type (2018-2023)
2.3.3 Global Non-opioid Topical Pain Relief Sale Price by Type (2018-2023)
2.4 Non-opioid Topical Pain Relief Segment by Application
2.4.1 Pharmacy
2.4.2 Clinic
2.4.3 Hospital
2.4.4 Others
2.5 Non-opioid Topical Pain Relief Sales by Application
2.5.1 Global Non-opioid Topical Pain Relief Sale Market Share by Application (2018-2023)
2.5.2 Global Non-opioid Topical Pain Relief Revenue and Market Share by Application (2018-2023)
2.5.3 Global Non-opioid Topical Pain Relief Sale Price by Application (2018-2023)
3 Global Non-opioid Topical Pain Relief by Company
3.1 Global Non-opioid Topical Pain Relief Breakdown Data by Company
3.1.1 Global Non-opioid Topical Pain Relief Annual Sales by Company (2018-2023)
3.1.2 Global Non-opioid Topical Pain Relief Sales Market Share by Company (2018-2023)
3.2 Global Non-opioid Topical Pain Relief Annual Revenue by Company (2018-2023)
3.2.1 Global Non-opioid Topical Pain Relief Revenue by Company (2018-2023)
3.2.2 Global Non-opioid Topical Pain Relief Revenue Market Share by Company (2018-2023)
3.3 Global Non-opioid Topical Pain Relief Sale Price by Company
3.4 Key Manufacturers Non-opioid Topical Pain Relief Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-opioid Topical Pain Relief Product Location Distribution
3.4.2 Players Non-opioid Topical Pain Relief Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Non-opioid Topical Pain Relief by Geographic Region
4.1 World Historic Non-opioid Topical Pain Relief Market Size by Geographic Region (2018-2023)
4.1.1 Global Non-opioid Topical Pain Relief Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Non-opioid Topical Pain Relief Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Non-opioid Topical Pain Relief Market Size by Country/Region (2018-2023)
4.2.1 Global Non-opioid Topical Pain Relief Annual Sales by Country/Region (2018-2023)
4.2.2 Global Non-opioid Topical Pain Relief Annual Revenue by Country/Region (2018-2023)
4.3 Americas Non-opioid Topical Pain Relief Sales Growth
4.4 APAC Non-opioid Topical Pain Relief Sales Growth
4.5 Europe Non-opioid Topical Pain Relief Sales Growth
4.6 Middle East & Africa Non-opioid Topical Pain Relief Sales Growth
5 Americas
5.1 Americas Non-opioid Topical Pain Relief Sales by Country
5.1.1 Americas Non-opioid Topical Pain Relief Sales by Country (2018-2023)
5.1.2 Americas Non-opioid Topical Pain Relief Revenue by Country (2018-2023)
5.2 Americas Non-opioid Topical Pain Relief Sales by Type
5.3 Americas Non-opioid Topical Pain Relief Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-opioid Topical Pain Relief Sales by Region
6.1.1 APAC Non-opioid Topical Pain Relief Sales by Region (2018-2023)
6.1.2 APAC Non-opioid Topical Pain Relief Revenue by Region (2018-2023)
6.2 APAC Non-opioid Topical Pain Relief Sales by Type
6.3 APAC Non-opioid Topical Pain Relief Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non-opioid Topical Pain Relief by Country
7.1.1 Europe Non-opioid Topical Pain Relief Sales by Country (2018-2023)
7.1.2 Europe Non-opioid Topical Pain Relief Revenue by Country (2018-2023)
7.2 Europe Non-opioid Topical Pain Relief Sales by Type
7.3 Europe Non-opioid Topical Pain Relief Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-opioid Topical Pain Relief by Country
8.1.1 Middle East & Africa Non-opioid Topical Pain Relief Sales by Country (2018-2023)
8.1.2 Middle East & Africa Non-opioid Topical Pain Relief Revenue by Country (2018-2023)
8.2 Middle East & Africa Non-opioid Topical Pain Relief Sales by Type
8.3 Middle East & Africa Non-opioid Topical Pain Relief Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-opioid Topical Pain Relief
10.3 Manufacturing Process Analysis of Non-opioid Topical Pain Relief
10.4 Industry Chain Structure of Non-opioid Topical Pain Relief
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-opioid Topical Pain Relief Distributors
11.3 Non-opioid Topical Pain Relief Customer
12 World Forecast Review for Non-opioid Topical Pain Relief by Geographic Region
12.1 Global Non-opioid Topical Pain Relief Market Size Forecast by Region
12.1.1 Global Non-opioid Topical Pain Relief Forecast by Region (2024-2029)
12.1.2 Global Non-opioid Topical Pain Relief Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-opioid Topical Pain Relief Forecast by Type
12.7 Global Non-opioid Topical Pain Relief Forecast by Application
13 Key Players Analysis
13.1 Johnson and Johnson
13.1.1 Johnson and Johnson Company Information
13.1.2 Johnson and Johnson Non-opioid Topical Pain Relief Product Portfolios and Specifications
13.1.3 Johnson and Johnson Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Johnson and Johnson Main Business Overview
13.1.5 Johnson and Johnson Latest Developments
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Information
13.2.2 GlaxoSmithKline Non-opioid Topical Pain Relief Product Portfolios and Specifications
13.2.3 GlaxoSmithKline Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GlaxoSmithKline Main Business Overview
13.2.5 GlaxoSmithKline Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Non-opioid Topical Pain Relief Product Portfolios and Specifications
13.3.3 Pfizer Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Hisamitsu
13.4.1 Hisamitsu Company Information
13.4.2 Hisamitsu Non-opioid Topical Pain Relief Product Portfolios and Specifications
13.4.3 Hisamitsu Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Hisamitsu Main Business Overview
13.4.5 Hisamitsu Latest Developments
13.5 Mylan
13.5.1 Mylan Company Information
13.5.2 Mylan Non-opioid Topical Pain Relief Product Portfolios and Specifications
13.5.3 Mylan Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mylan Main Business Overview
13.5.5 Mylan Latest Developments
13.6 Reckitt Benckiser Group
13.6.1 Reckitt Benckiser Group Company Information
13.6.2 Reckitt Benckiser Group Non-opioid Topical Pain Relief Product Portfolios and Specifications
13.6.3 Reckitt Benckiser Group Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Reckitt Benckiser Group Main Business Overview
13.6.5 Reckitt Benckiser Group Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Non-opioid Topical Pain Relief Product Portfolios and Specifications
13.7.3 Sanofi Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Teva Pharmaceutical
13.8.1 Teva Pharmaceutical Company Information
13.8.2 Teva Pharmaceutical Non-opioid Topical Pain Relief Product Portfolios and Specifications
13.8.3 Teva Pharmaceutical Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Teva Pharmaceutical Main Business Overview
13.8.5 Teva Pharmaceutical Latest Developments
13.9 Sun Pharmaceutical Industries
13.9.1 Sun Pharmaceutical Industries Company Information
13.9.2 Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Product Portfolios and Specifications
13.9.3 Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sun Pharmaceutical Industries Main Business Overview
13.9.5 Sun Pharmaceutical Industries Latest Developments
13.10 Lingrui Pharmaceutical
13.10.1 Lingrui Pharmaceutical Company Information
13.10.2 Lingrui Pharmaceutical Non-opioid Topical Pain Relief Product Portfolios and Specifications
13.10.3 Lingrui Pharmaceutical Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Lingrui Pharmaceutical Main Business Overview
13.10.5 Lingrui Pharmaceutical Latest Developments
13.11 Tibet Cheezheng Tibetan Medicine
13.11.1 Tibet Cheezheng Tibetan Medicine Company Information
13.11.2 Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Product Portfolios and Specifications
13.11.3 Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Tibet Cheezheng Tibetan Medicine Main Business Overview
13.11.5 Tibet Cheezheng Tibetan Medicine Latest Developments
13.12 China Resources Sanjiu Medical & Pharmaceutical
13.12.1 China Resources Sanjiu Medical & Pharmaceutical Company Information
13.12.2 China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Product Portfolios and Specifications
13.12.3 China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 China Resources Sanjiu Medical & Pharmaceutical Main Business Overview
13.12.5 China Resources Sanjiu Medical & Pharmaceutical Latest Developments
13.13 Topical BioMedics
13.13.1 Topical BioMedics Company Information
13.13.2 Topical BioMedics Non-opioid Topical Pain Relief Product Portfolios and Specifications
13.13.3 Topical BioMedics Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Topical BioMedics Main Business Overview
13.13.5 Topical BioMedics Latest Developments
13.14 AdvaCare Pharma
13.14.1 AdvaCare Pharma Company Information
13.14.2 AdvaCare Pharma Non-opioid Topical Pain Relief Product Portfolios and Specifications
13.14.3 AdvaCare Pharma Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 AdvaCare Pharma Main Business Overview
13.14.5 AdvaCare Pharma Latest Developments
13.15 Abacus Health Products
13.15.1 Abacus Health Products Company Information
13.15.2 Abacus Health Products Non-opioid Topical Pain Relief Product Portfolios and Specifications
13.15.3 Abacus Health Products Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Abacus Health Products Main Business Overview
13.15.5 Abacus Health Products Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Non-opioid Topical Pain Relief Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Non-opioid Topical Pain Relief Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Prescription Pain Relief
Table 4. Major Players of Over-The-Counter Pain Relief
Table 5. Global Non-opioid Topical Pain Relief Sales by Type (2018-2023) & (K Units)
Table 6. Global Non-opioid Topical Pain Relief Sales Market Share by Type (2018-2023)
Table 7. Global Non-opioid Topical Pain Relief Revenue by Type (2018-2023) & ($ million)
Table 8. Global Non-opioid Topical Pain Relief Revenue Market Share by Type (2018-2023)
Table 9. Global Non-opioid Topical Pain Relief Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Non-opioid Topical Pain Relief Sales by Application (2018-2023) & (K Units)
Table 11. Global Non-opioid Topical Pain Relief Sales Market Share by Application (2018-2023)
Table 12. Global Non-opioid Topical Pain Relief Revenue by Application (2018-2023)
Table 13. Global Non-opioid Topical Pain Relief Revenue Market Share by Application (2018-2023)
Table 14. Global Non-opioid Topical Pain Relief Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Non-opioid Topical Pain Relief Sales by Company (2018-2023) & (K Units)
Table 16. Global Non-opioid Topical Pain Relief Sales Market Share by Company (2018-2023)
Table 17. Global Non-opioid Topical Pain Relief Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Non-opioid Topical Pain Relief Revenue Market Share by Company (2018-2023)
Table 19. Global Non-opioid Topical Pain Relief Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Non-opioid Topical Pain Relief Producing Area Distribution and Sales Area
Table 21. Players Non-opioid Topical Pain Relief Products Offered
Table 22. Non-opioid Topical Pain Relief Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Non-opioid Topical Pain Relief Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Non-opioid Topical Pain Relief Sales Market Share Geographic Region (2018-2023)
Table 27. Global Non-opioid Topical Pain Relief Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Non-opioid Topical Pain Relief Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Non-opioid Topical Pain Relief Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Non-opioid Topical Pain Relief Sales Market Share by Country/Region (2018-2023)
Table 31. Global Non-opioid Topical Pain Relief Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Non-opioid Topical Pain Relief Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Non-opioid Topical Pain Relief Sales by Country (2018-2023) & (K Units)
Table 34. Americas Non-opioid Topical Pain Relief Sales Market Share by Country (2018-2023)
Table 35. Americas Non-opioid Topical Pain Relief Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Non-opioid Topical Pain Relief Revenue Market Share by Country (2018-2023)
Table 37. Americas Non-opioid Topical Pain Relief Sales by Type (2018-2023) & (K Units)
Table 38. Americas Non-opioid Topical Pain Relief Sales by Application (2018-2023) & (K Units)
Table 39. APAC Non-opioid Topical Pain Relief Sales by Region (2018-2023) & (K Units)
Table 40. APAC Non-opioid Topical Pain Relief Sales Market Share by Region (2018-2023)
Table 41. APAC Non-opioid Topical Pain Relief Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Non-opioid Topical Pain Relief Revenue Market Share by Region (2018-2023)
Table 43. APAC Non-opioid Topical Pain Relief Sales by Type (2018-2023) & (K Units)
Table 44. APAC Non-opioid Topical Pain Relief Sales by Application (2018-2023) & (K Units)
Table 45. Europe Non-opioid Topical Pain Relief Sales by Country (2018-2023) & (K Units)
Table 46. Europe Non-opioid Topical Pain Relief Sales Market Share by Country (2018-2023)
Table 47. Europe Non-opioid Topical Pain Relief Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Non-opioid Topical Pain Relief Revenue Market Share by Country (2018-2023)
Table 49. Europe Non-opioid Topical Pain Relief Sales by Type (2018-2023) & (K Units)
Table 50. Europe Non-opioid Topical Pain Relief Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Non-opioid Topical Pain Relief Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Non-opioid Topical Pain Relief Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Non-opioid Topical Pain Relief Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Non-opioid Topical Pain Relief Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Non-opioid Topical Pain Relief Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Non-opioid Topical Pain Relief Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Non-opioid Topical Pain Relief
Table 58. Key Market Challenges & Risks of Non-opioid Topical Pain Relief
Table 59. Key Industry Trends of Non-opioid Topical Pain Relief
Table 60. Non-opioid Topical Pain Relief Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Non-opioid Topical Pain Relief Distributors List
Table 63. Non-opioid Topical Pain Relief Customer List
Table 64. Global Non-opioid Topical Pain Relief Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Non-opioid Topical Pain Relief Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Non-opioid Topical Pain Relief Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Non-opioid Topical Pain Relief Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Non-opioid Topical Pain Relief Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Non-opioid Topical Pain Relief Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Non-opioid Topical Pain Relief Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Non-opioid Topical Pain Relief Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Non-opioid Topical Pain Relief Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Non-opioid Topical Pain Relief Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Non-opioid Topical Pain Relief Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Non-opioid Topical Pain Relief Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Non-opioid Topical Pain Relief Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Non-opioid Topical Pain Relief Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Johnson and Johnson Basic Information, Non-opioid Topical Pain Relief Manufacturing Base, Sales Area and Its Competitors
Table 79. Johnson and Johnson Non-opioid Topical Pain Relief Product Portfolios and Specifications
Table 80. Johnson and Johnson Non-opioid Topical Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Johnson and Johnson Main Business
Table 82. Johnson and Johnson Latest Developments
Table 83. GlaxoSmithKline Basic Information, Non-opioid Topical Pain Relief Manufacturing Base, Sales Area and Its Competitors
Table 84. GlaxoSmithKline Non-opioid Topical Pain Relief Product Portfolios and Specifications
Table 85. GlaxoSmithKline Non-opioid Topical Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. GlaxoSmithKline Main Business
Table 87. GlaxoSmithKline Latest Developments
Table 88. Pfizer Basic Information, Non-opioid Topical Pain Relief Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer Non-opioid Topical Pain Relief Product Portfolios and Specifications
Table 90. Pfizer Non-opioid Topical Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. Hisamitsu Basic Information, Non-opioid Topical Pain Relief Manufacturing Base, Sales Area and Its Competitors
Table 94. Hisamitsu Non-opioid Topical Pain Relief Product Portfolios and Specifications
Table 95. Hisamitsu Non-opioid Topical Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Hisamitsu Main Business
Table 97. Hisamitsu Latest Developments
Table 98. Mylan Basic Information, Non-opioid Topical Pain Relief Manufacturing Base, Sales Area and Its Competitors
Table 99. Mylan Non-opioid Topical Pain Relief Product Portfolios and Specifications
Table 100. Mylan Non-opioid Topical Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Mylan Main Business
Table 102. Mylan Latest Developments
Table 103. Reckitt Benckiser Group Basic Information, Non-opioid Topical Pain Relief Manufacturing Base, Sales Area and Its Competitors
Table 104. Reckitt Benckiser Group Non-opioid Topical Pain Relief Product Portfolios and Specifications
Table 105. Reckitt Benckiser Group Non-opioid Topical Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Reckitt Benckiser Group Main Business
Table 107. Reckitt Benckiser Group Latest Developments
Table 108. Sanofi Basic Information, Non-opioid Topical Pain Relief Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanofi Non-opioid Topical Pain Relief Product Portfolios and Specifications
Table 110. Sanofi Non-opioid Topical Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Sanofi Main Business
Table 112. Sanofi Latest Developments
Table 113. Teva Pharmaceutical Basic Information, Non-opioid Topical Pain Relief Manufacturing Base, Sales Area and Its Competitors
Table 114. Teva Pharmaceutical Non-opioid Topical Pain Relief Product Portfolios and Specifications
Table 115. Teva Pharmaceutical Non-opioid Topical Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Teva Pharmaceutical Main Business
Table 117. Teva Pharmaceutical Latest Developments
Table 118. Sun Pharmaceutical Industries Basic Information, Non-opioid Topical Pain Relief Manufacturing Base, Sales Area and Its Competitors
Table 119. Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Product Portfolios and Specifications
Table 120. Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Sun Pharmaceutical Industries Main Business
Table 122. Sun Pharmaceutical Industries Latest Developments
Table 123. Lingrui Pharmaceutical Basic Information, Non-opioid Topical Pain Relief Manufacturing Base, Sales Area and Its Competitors
Table 124. Lingrui Pharmaceutical Non-opioid Topical Pain Relief Product Portfolios and Specifications
Table 125. Lingrui Pharmaceutical Non-opioid Topical Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Lingrui Pharmaceutical Main Business
Table 127. Lingrui Pharmaceutical Latest Developments
Table 128. Tibet Cheezheng Tibetan Medicine Basic Information, Non-opioid Topical Pain Relief Manufacturing Base, Sales Area and Its Competitors
Table 129. Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Product Portfolios and Specifications
Table 130. Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Tibet Cheezheng Tibetan Medicine Main Business
Table 132. Tibet Cheezheng Tibetan Medicine Latest Developments
Table 133. China Resources Sanjiu Medical & Pharmaceutical Basic Information, Non-opioid Topical Pain Relief Manufacturing Base, Sales Area and Its Competitors
Table 134. China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Product Portfolios and Specifications
Table 135. China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. China Resources Sanjiu Medical & Pharmaceutical Main Business
Table 137. China Resources Sanjiu Medical & Pharmaceutical Latest Developments
Table 138. Topical BioMedics Basic Information, Non-opioid Topical Pain Relief Manufacturing Base, Sales Area and Its Competitors
Table 139. Topical BioMedics Non-opioid Topical Pain Relief Product Portfolios and Specifications
Table 140. Topical BioMedics Non-opioid Topical Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Topical BioMedics Main Business
Table 142. Topical BioMedics Latest Developments
Table 143. AdvaCare Pharma Basic Information, Non-opioid Topical Pain Relief Manufacturing Base, Sales Area and Its Competitors
Table 144. AdvaCare Pharma Non-opioid Topical Pain Relief Product Portfolios and Specifications
Table 145. AdvaCare Pharma Non-opioid Topical Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. AdvaCare Pharma Main Business
Table 147. AdvaCare Pharma Latest Developments
Table 148. Abacus Health Products Basic Information, Non-opioid Topical Pain Relief Manufacturing Base, Sales Area and Its Competitors
Table 149. Abacus Health Products Non-opioid Topical Pain Relief Product Portfolios and Specifications
Table 150. Abacus Health Products Non-opioid Topical Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Abacus Health Products Main Business
Table 152. Abacus Health Products Latest Developments
List of Figures
Figure 1. Picture of Non-opioid Topical Pain Relief
Figure 2. Non-opioid Topical Pain Relief Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-opioid Topical Pain Relief Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Non-opioid Topical Pain Relief Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Non-opioid Topical Pain Relief Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Prescription Pain Relief
Figure 10. Product Picture of Over-The-Counter Pain Relief
Figure 11. Global Non-opioid Topical Pain Relief Sales Market Share by Type in 2022
Figure 12. Global Non-opioid Topical Pain Relief Revenue Market Share by Type (2018-2023)
Figure 13. Non-opioid Topical Pain Relief Consumed in Pharmacy
Figure 14. Global Non-opioid Topical Pain Relief Market: Pharmacy (2018-2023) & (K Units)
Figure 15. Non-opioid Topical Pain Relief Consumed in Clinic
Figure 16. Global Non-opioid Topical Pain Relief Market: Clinic (2018-2023) & (K Units)
Figure 17. Non-opioid Topical Pain Relief Consumed in Hospital
Figure 18. Global Non-opioid Topical Pain Relief Market: Hospital (2018-2023) & (K Units)
Figure 19. Non-opioid Topical Pain Relief Consumed in Others
Figure 20. Global Non-opioid Topical Pain Relief Market: Others (2018-2023) & (K Units)
Figure 21. Global Non-opioid Topical Pain Relief Sales Market Share by Application (2022)
Figure 22. Global Non-opioid Topical Pain Relief Revenue Market Share by Application in 2022
Figure 23. Non-opioid Topical Pain Relief Sales Market by Company in 2022 (K Units)
Figure 24. Global Non-opioid Topical Pain Relief Sales Market Share by Company in 2022
Figure 25. Non-opioid Topical Pain Relief Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Non-opioid Topical Pain Relief Revenue Market Share by Company in 2022
Figure 27. Global Non-opioid Topical Pain Relief Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Non-opioid Topical Pain Relief Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Non-opioid Topical Pain Relief Sales 2018-2023 (K Units)
Figure 30. Americas Non-opioid Topical Pain Relief Revenue 2018-2023 ($ Millions)
Figure 31. APAC Non-opioid Topical Pain Relief Sales 2018-2023 (K Units)
Figure 32. APAC Non-opioid Topical Pain Relief Revenue 2018-2023 ($ Millions)
Figure 33. Europe Non-opioid Topical Pain Relief Sales 2018-2023 (K Units)
Figure 34. Europe Non-opioid Topical Pain Relief Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Non-opioid Topical Pain Relief Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Non-opioid Topical Pain Relief Revenue 2018-2023 ($ Millions)
Figure 37. Americas Non-opioid Topical Pain Relief Sales Market Share by Country in 2022
Figure 38. Americas Non-opioid Topical Pain Relief Revenue Market Share by Country in 2022
Figure 39. Americas Non-opioid Topical Pain Relief Sales Market Share by Type (2018-2023)
Figure 40. Americas Non-opioid Topical Pain Relief Sales Market Share by Application (2018-2023)
Figure 41. United States Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Non-opioid Topical Pain Relief Sales Market Share by Region in 2022
Figure 46. APAC Non-opioid Topical Pain Relief Revenue Market Share by Regions in 2022
Figure 47. APAC Non-opioid Topical Pain Relief Sales Market Share by Type (2018-2023)
Figure 48. APAC Non-opioid Topical Pain Relief Sales Market Share by Application (2018-2023)
Figure 49. China Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Non-opioid Topical Pain Relief Sales Market Share by Country in 2022
Figure 57. Europe Non-opioid Topical Pain Relief Revenue Market Share by Country in 2022
Figure 58. Europe Non-opioid Topical Pain Relief Sales Market Share by Type (2018-2023)
Figure 59. Europe Non-opioid Topical Pain Relief Sales Market Share by Application (2018-2023)
Figure 60. Germany Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Non-opioid Topical Pain Relief Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Non-opioid Topical Pain Relief Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Non-opioid Topical Pain Relief Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Non-opioid Topical Pain Relief Sales Market Share by Application (2018-2023)
Figure 69. Egypt Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Non-opioid Topical Pain Relief Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Non-opioid Topical Pain Relief in 2022
Figure 75. Manufacturing Process Analysis of Non-opioid Topical Pain Relief
Figure 76. Industry Chain Structure of Non-opioid Topical Pain Relief
Figure 77. Channels of Distribution
Figure 78. Global Non-opioid Topical Pain Relief Sales Market Forecast by Region (2024-2029)
Figure 79. Global Non-opioid Topical Pain Relief Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Non-opioid Topical Pain Relief Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Non-opioid Topical Pain Relief Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Non-opioid Topical Pain Relief Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Non-opioid Topical Pain Relief Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の非オピオイド局所鎮痛剤市場予測 2023年-2029年] (コード：LP23DC08034)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の非オピオイド局所鎮痛剤市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の疼痛治療製品市場予測 2023年-2029年
  • 世界の局所投与アプリケーター市場予測 2023年-2029年
  • 世界の疼痛治療用衝撃波装置市場予測 2023年-2029年
  • 世界のレリーフ彫刻機市場予測 2023年-2029年
  • 世界の空圧式エアリリーフバルブ市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆